SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-129488
Filing Date
2019-04-30
Accepted
2019-04-30 16:33:57
Documents
5
Period of Report
2019-06-12
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d728572ddef14a.htm DEF 14A 1005869
2 GRAPHIC g728572g36i66.jpg GRAPHIC 6692
3 GRAPHIC g728572g64s91.jpg GRAPHIC 54628
4 GRAPHIC g728572g76l04.jpg GRAPHIC 101501
5 GRAPHIC g728572pc01.jpg GRAPHIC 4838
  Complete submission text file 0001193125-19-129488.txt   1238588
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 19782329
SIC: 2834 Pharmaceutical Preparations